Varenicline
Product Images NDC 60687-648

7 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 60687-648). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

155999ed 864c 1905 E063 6394a90a99ca

155999ed 864c 1905 E063 6394a90a99ca
Varenicline round blue tablet imprinted with 'P' on one side and '156' on the other side, manufactured by American Health Packaging. No strength or dosage form confirmed by image alone.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of varenicline tartrate, the active ingredient in Varenicline tablets. The image depicts molecular components and bonding arrangements characteristic of varenicline tartrate.*
FDA Label Image

Figure 1: Continuous Abstinence, Weeks 9 Through 12 (Figure 1)

Figure 1: Continuous Abstinence, Weeks 9 Through 12 (Figure 1)
A bar chart comparing efficacy percentages of Varenicline and placebo across four studies, labeled Study 2 to Study 5. Each study shows three bars representing Varenicline doses or regimens, Bupropion SR 150 mg BID in Studies 4 and 5, and placebo, with error bars indicating variability. The y-axis is labeled from 0% to 60%.*
FDA Label Image

Figure 2: Continuous Abstinence, Weeks 9 Through 52 (Figure 2)

Figure 2: Continuous Abstinence, Weeks 9 Through 52 (Figure 2)
A bar chart comparing the effectiveness of Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, and Bupropion SR 150 mg BID against placebo across four separate studies. The vertical axis represents percentage values ranging from 0% to 35%, with error bars shown for each treatment group.*
FDA Label Image

Figure 3: Continuous Abstinence Rate During Nontreatment Follow-up (Figure 3)

Figure 3: Continuous Abstinence Rate During Nontreatment Follow-up (Figure 3)
A line graph showing the percentage of continuous abstinent subjects over a nontreatment follow-up period in weeks. Two lines are present: one representing Varenicline 1.0 mg BID and the other a placebo. The vertical axis indicates % continuous abstinent, ranging from 0 to 100. The horizontal axis shows follow-up weeks ranging approximately from 25 to 52 weeks. The Varenicline line consistently shows higher abstinence percentages than the placebo line throughout the follow-up period.*
FDA Label Image

1 mg Varenicline Tablets Carton.jpg (1 mg Varenicline Tablets Carton)

1 mg Varenicline Tablets Carton.jpg (1 mg Varenicline Tablets Carton)
Label for Varenicline Tablets 1 mg by American Health Packaging. The package contains 30 tablets (3 blister packs of 10). It includes storage instructions, pharmacist dispensing guidance, and a QR code for medication guide and prescribing info. The label states Rx Only and provides the NDC 60687-648-21.*
FDA Label Image

1 mg Varenicline Tablets Blister.jpg (1 mg Varenicline Tablets Blister)

1 mg Varenicline Tablets Blister.jpg (1 mg Varenicline Tablets Blister)
Multiple identical labels for Varenicline 1 mg tablets from American Health Packaging. Each label includes the product name, strength, dosage form, barcodes, product NDC 60687-648, expiration date, lot number space, and manufacturer location in Columbus, Ohio.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.